Company / SG&A per Share
AVADEL PHARMACEUTICALS PLC SG&A per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.90
FY2024
5-year range
$0.59 / $1.90
FY2020-FY2024
Trend
+0.6%
vs FY2023
Sector context
#81 of 210
Health Care
What the data says
At $1.90, AVADEL PHARMACEUTICALS PLC's sg&a per share ranks #130 of 210 in the Health Care sector. SG&A per Share has increased for 4 consecutive years, from $0.59 in FY2020 to $1.90 in FY2024.
Based on SEC 10-K filings.
1.90 in FY2024 with a 5-year CAGR of +18.7%.
Increased from $1.24 to $1.90 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +17.6%
- 5-Year CAGR
- +18.7%
- 10-Year CAGR
- -
Sector benchmark
#130 of 210 in Health CareTop 61% of 210This company $1.90 Sector average $40.75
▼
-95.3% below sector average
Key checks
Key Insights
- AVADEL PHARMACEUTICALS PLC's sg&a per share has grown for 4 consecutive years.
- In FY2024, sg&a per share increased 0.6% year-over-year.
- Ranks #81 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.90 | +0.6% |
| FY2023 | $1.89 | +52.6% |
| FY2022 | $1.24 | +6.0% |
| FY2021 | $1.17 | +98.4% |
| FY2020 | $0.59 | -26.9% |
| FY2019 | $0.81 | -70.0% |
| FY2018 | $2.69 | +90.8% |
| FY2017 | $1.41 | +31.6% |
| FY2016 | $1.07 | +115.2% |
| FY2015 | $0.50 | +14.8% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026